Drug Shortage Report for CAPRELSA

Last updated on 2022-06-30 History
Report ID 155030
Drug Identification Number 02378582
Brand name CAPRELSA
Common or Proper name Caprelsa
Company Name SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) VANDETANIB
Strength(s) 100MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 30
ATC code L01XE
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2022-12-01
Actual start date
Estimated end date 2023-04-28
Actual end date 2022-06-30
Shortage status Avoided shortage
Updated date 2022-06-30
Company comments Manufacturing change. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments
Tier 3 Status No
Company contact information Customer service contact info: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2022-06-30 French Compare
v9 2022-06-30 English Compare
v8 2022-06-27 French Compare
v7 2022-06-27 English Compare
v6 2022-06-15 French Compare
v5 2022-06-15 English Compare
v4 2022-04-08 French Compare
v3 2022-04-08 English Compare
v2 2022-02-15 French Compare
v1 2022-02-15 English Compare

Showing 1 to 10 of 10